Loading clinical trials...
Loading clinical trials...
Single-Center, Randomized, Double-Blind, Placebo-Controlled, Three-Way Crossover Study to Evaluate the Safety, Tolerability and Clinical Activity of a Single Dose of ASM-024 Administered by Inhalation to Subjects With Stable Moderate Asthma
Conditions
Interventions
ASM-024
ASM-024 100 mg
+1 more
Locations
3
Canada
McMaster University
Hamilton, Ontario, Canada
Anapharm
Montreal, Quebec, Canada
Centre de Recherche Institut universitaire de cardiologie et de pneumologie de Québec
Québec, Quebec, Canada
Start Date
August 1, 2010
Primary Completion Date
December 1, 2011
Completion Date
February 1, 2012
Last Updated
March 15, 2012
NCT02327897
NCT07486401
NCT07219173
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
Asmacure Ltée
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions